These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10491434)

  • 41. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
    Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
    Iavarone A; Massagué J
    Nature; 1997 May; 387(6631):417-22. PubMed ID: 9163429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
    Matsuoka M; Tani K; Asano S
    Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p16(INK4a) Peptide mimetics identified via virtual screening.
    Klein MA; Mayo KH; Kratzke RA
    Bioorg Med Chem Lett; 2010 Jan; 20(1):403-5. PubMed ID: 19914831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16.
    Mahajan A; Guo Y; Yuan C; Weghorst CM; Tsai MD; Li J
    J Mol Biol; 2007 Nov; 373(4):990-1005. PubMed ID: 17881001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms.
    Ruas M; Gregory F; Jones R; Poolman R; Starborg M; Rowe J; Brookes S; Peters G
    Mol Cell Biol; 2007 Jun; 27(12):4273-82. PubMed ID: 17420273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CDK redundancy guarantees cell cycle progression in Rb-negative tumor cells independently of their p16 status.
    Santamariña M; Hernández G; Zalvide J
    Cell Cycle; 2008 Jul; 7(13):1962-72. PubMed ID: 18604173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Re: biologic and biochemical analyses of p16(INK4a) mutations from primary tumors.
    Hansson J; Hashemi J; Linder S; Platz A
    J Natl Cancer Inst; 2000 May; 92(9):758-60. PubMed ID: 10793118
    [No Abstract]   [Full Text] [Related]  

  • 50. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.
    Omura-Minamisawa M; Diccianni MB; Chang RC; Batova A; Bridgeman LJ; Schiff J; Cohn SL; London WB; Yu AL
    Clin Cancer Res; 2001 Nov; 7(11):3481-90. PubMed ID: 11705866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
    Newton Bishop JA; Harland M; Bennett DC; Bataille V; Goldstein AM; Tucker MA; Ponder BA; Cuzick J; Selby P; Bishop DT
    Br J Cancer; 1999 Apr; 80(1-2):295-300. PubMed ID: 10390011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A.
    Li J; Byeon IJ; Ericson K; Poi MJ; O'Maille P; Selby T; Tsai MD
    Biochemistry; 1999 Mar; 38(10):2930-40. PubMed ID: 10074345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
    Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
    Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma.
    Yao J; Pollock RE; Lang A; Tan M; Pisters PW; Goodrich D; El-Naggar A; Yu D
    Clin Cancer Res; 1998 Apr; 4(4):1065-70. PubMed ID: 9563903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and characterization of Syrian golden hamster p16, a homologue of human tumor suppressor p16 INK4A.
    Li J; Qin D; Knobloch TJ; Tsai MD; Weghorst CM; Melvin WS; Muscarella P
    Biochem Biophys Res Commun; 2003 May; 304(2):241-7. PubMed ID: 12711305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
    Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information.
    Ruas M; Brookes S; McDonald NQ; Peters G
    Oncogene; 1999 Sep; 18(39):5423-34. PubMed ID: 10498896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb.
    Li J; Tsai MD
    Biochemistry; 2002 Mar; 41(12):3977-83. PubMed ID: 11900540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.